Facilitating smoking cessation using reduced nicotine cigarettes: Intervention development and RCT study design.
Melissa R Conn1, Thomas H Brandon2, Yenis L Lorenzo1
1Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States of America.
This study developed a new smoking cessation program using reduced nicotine cigarettes to aid quitting. The facilitated extinction intervention aims to reduce cravings and improve success rates for smokers.
Area of Science:
- Addiction Medicine
- Behavioral Psychology
- Nicotine Science
Background:
- Nicotine's reinforcing effects hinder smoking cessation.
- Reducing nicotine in cigarettes may facilitate quitting through extinction learning.
- Novel interventions are needed to optimize smoking cessation success.
Purpose of the Study:
- To develop and evaluate a novel facilitated extinction (FE) intervention for smoking cessation.
- To assess the efficacy of reduced nicotine cigarettes in reducing smoking reinforcement.
- To compare FE intervention with standard cognitive-behavioral therapy.
Main Methods:
- Qualitative methods and pilot testing informed FE intervention development.
- A randomized controlled trial (RCT) is evaluating the FE intervention.
- Participants (n=208) are randomized to FE vs. standard intervention and immediate vs. gradual transition to very low nicotine content (VLNC) cigarettes.
Main Results:
- The RCT is ongoing, evaluating the primary aims.
- The study design allows for comparison of different nicotine reduction schedules.
- Participant recruitment and randomization are complete.
Conclusions:
- The FE intervention, utilizing VLNC cigarettes, presents a promising approach to smoking cessation.
- Optimizing extinction learning during a pre-quit period may enhance cessation outcomes.
- Further results from the RCT will determine the intervention's efficacy.
More Related Videos
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
06:07Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Statistical Methods for Analyzing Epidemiological Data
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
CNS Depressants: Alcohol and Nicotine
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
